Syncom Formulations (India) Limited

Web: syncomformulations.com NSE: SYNCOMF BSE: 524470 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

20 1(-5%)

Volume

18L as on 23, Jun

Open

High

Low

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

62/100

Growth Score

90/100

Valuation Score

50/100

Momentum Score

25/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,908

No. of Shares

P/E

60.04

P/B

6.65

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

11.08

ROCE

Profit Growth

Listing Date

18-Nov-22

Promoter Holding

50.57%

FII Holding

0.35%

DII Holding

Price Chart

Price Performance

1 Week3%

1 Month3%

3 Months24%

6 Months13%

1 Year13%

YTD13%

Moving Average

5 Day SMA14

10 Day SMA14

20 Day SMA14

30 Day SMA14

50 Day SMA14

61 Day SMA14

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	14	14	14	14
Resistance 2	14	14	14	14
Resistance 1	14	14	14	14
Pivot Point	14	14	14	14
Support 1	14	14	14	14
Support 2	14	14	14	14
Support 3	14	14	14	14

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(4.51) 50.57%	(2.11) 46.12%	(0.01) 44.01%	(0.01) 44.01%
FIIs	(0.11) 0.35%	(-0.11) 0.21%	(0.21) 0.26%	(-0.31) 0.10%	(0.31) 0.41%	(0.01) 0.11%	(0.01) 0.13%	(0.01) 0.10%	(0.01) 0.09%	(0.11) 0.08%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-0.61) 0.00%	(0.01) 0.58%
Public	49.07%	49.23%	49.17%	49.33%	49.02%	49.32%	49.30%	49.34%	49.34%	49.35%	49.44%	49.44%	49.44%	49.44%	49.43%	49.43%	49.43%	53.88%	55.99%	55.40%
No. of Shareholders	422,114	431,690	442,280	457,364	471,066	484,529	489,520	469,242	376,530	325,761	289,982	224,252	224,925	227,478	232,069	232,750	235,517	232,617	188,981	120,800

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Mar 2014
Sales	126	135	115	122	117	149	128	102	87	75	65	64	60	61	57	54	51	58	57	53	42.75
Sales Growth % (YoY)	7.4%	-9%	-9.7%	19%	34%	99.6%	95.8%	60.3%	45.8%	22.3%	13.5%	17.2%	16.4%	4.7%	0.3%	2.9%	-	-	-	-	22.8%
Sales Growth % (QoQ)	-6.7%	17.4%	-5.7%	4.3%	-21.5%	16.4%	25.5%	17.2%	16%	15.4%	1.6%	6.7%	-1.6%	7%	5.6%	5.9%	-12.1%	1.8%	7.5%	24%	-
Expenses	99	113	94	103	101	131	113	90	77	65	58	57	53	55	51	50	48	56	52	47	38
Operating Profit	26	22	21	18	16	18	15	12	10	9	7	6	6	6	6	4	3	2	5	6	4.75
OPM %	21	16	18	15	14	12	12	12	12	13	11	10	11	10	10	8	7	4	9	11	11.11
Other Income	8	15	6	5	6	7	4	4	1	3	5	4	2	7	2	3	3	6	2	3	0.54
Interest	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	0	1	0	0	0.06
Depreciation	2	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0.77
Profit before tax	32	34	25	22	20	23	17	15	10	10	9	8	6	10	6	5	5	6	6	7	4.46
Tax %	23	25	25	25	22	24	25	25	24	26	25	23	28	18	30	33	22	16	33	23	41.26
Net Profit	25	25	19	17	16	18	13	11	8	7	7	7	4	8	4	4	4	5	4	6	2.62
Net Profit Growth % (QoQ)	-	31.6%	11.8%	6.2%	-11.1%	38.5%	18.2%	37.5%	14.3%	-	-	75%	-50%	100%	-	-	-20%	25%	-33.3%	129%	-
Net Profit Growth % (YoY)	56.2%	38.9%	46.2%	54.5%	100%	157.1%	85.7%	57.1%	100%	-12.5%	75%	75%	-	60%	-	-33.3%	-	-	-	-	-
TTM Net Profit	86	77	70	64	58	50	39	33	29	25	26	23	20	20	17	17	19	15	10	6	0
EPS in Rs	0.26	0.27	0.2	0.18	0.17	0.19	0.14	0.12	0.08	0.08	0.07	0.07	0.05	0.09	0.04	0.04	0.04	0.06	0.05	0.07	0.03

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	489	463	262	222	216	185	184	173	151	115
Sales Growth %	5.7%	76.6%	18.3%	2.6%	-	0.5%	6.1%	14.6%	31.6%	-
Expenses	412	408	232	202	196	168	167	155	135	104
Operating Profit	77	54	30	20	20	17	17	18	16	11
OPM %	16	12	11	9	9	9	9	11	11	9
Other Income	31	17	14	15	12	3	3	1	1	1
Interest	1	1	5	3	2	0	0	0	0	1
Depreciation	7	5	5	5	4	3	3	3	3	3
Profit before tax	101	66	34	27	26	16	16	16	14	8
Tax %	24	25	25	24	24	34	36	38	33	33
Net Profit	76	49	25	20	20	11	10	10	9	6
Net Profit Growth %	55.1%	96%	25%	-	81.8%	10%	-	11.1%	50%	-
EPS in Rs	0.81	0.53	0.27	0.21	0.23	0.13	0.13	0.13	0.12	0.07
Dividend Payout %	0	0	0	0	13	15	15	16	17	24

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	58	23	-6	11	16	14	24	0	7	6
Cash from Investing Activity	-51	-18	83	-45	-27	-18	-23	1	-4	0
Cash from Financing Activity	-3	-68	-15	35	8	5	-2	1	-1	-6
Net Cash Flow	4	-63	62	1	-2	1	-1	2	2	-1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	94	94	94	94	94	94	86	78	78	78	78	22
Reserves	321	284	248	220	194	162	136	39	31	22	17	65
Borrowings	1	1	5	14	72	83	58	12	6	6	3	2
Other Liabilities	117	77	67	45	44	39	28	50	61	31	42	33
Total Liabilities	534	456	413	372	405	378	308	180	175	138	140	123
Fixed Assets	184	124	125	117	120	91	94	55	46	46	50	50
CWIP	0	8	0	1	0	26	6	0	5	0	0	0
Investments	109	148	93	86	66	64	43	36	23	6	9	7
Other Assets	241	176	196	168	219	197	165	89	101	85	80	66
Total Assets	534	456	413	372	405	378	308	180	175	138	140	123

Delivery

Delivery Data: SYNCOMF

#	Date	13 77% 23	Value (Cr)	Q/T 447	Del 40	Del 13
1	4-Sep	21	35	428	35	12
2	3-Sep	21	55	545	38	21
3	2-Sep	21	61	436	29	18
4	1-Sep	20	31	495	32	10
5	31-Aug	19	32	380	32	10
6	28-Aug	19	111	211	23	25
7	27-Aug	17	15	265	31	5
8	26-Aug	17	9	454	46	4
9	25-Aug	18	21	304	30	6
10	24-Aug	17	29	413	37	11
11	21-Aug	16	12	397	43	5
12	20-Aug	15	4	443	52	2
13	19-Aug	15	3	403	49	2
14	18-Aug	16	8	529	41	3
15	17-Aug	15	6	522	40	2
16	14-Aug	15	7	502	44	3
17	13-Aug	15	10	575	36	3
18	12-Aug	16	95	267	15	14
19	11-Aug	15	7	489	36	3
20	10-Aug	14	24	327	27	6
21	7-Aug	13	3	529	55	1
22	6-Aug	13	3	483	44	1
23	5-Aug	13	2	390	66	1
24	4-Aug	13	2	411	46	1
25	3-Aug	13	1	370	55	1
26	31-Jul	13	1	270	59	0
27	30-Jul	13	1	249	54	1
28	29-Jul	13	1	244	63	1
29	28-Jul	13	1	224	53	1
30	27-Jul	13	1	309	49	1
31	24-Jul	13	2	390	61	1
32	23-Jul	13	1	380	45	1
33	22-Jul	13	2	321	59	1
34	21-Jul	14	1	391	62	1
35	20-Jul	14	1	398	50	1
36	17-Jul	13	2	437	54	1
37	16-Jul	14	2	387	55	1
38	15-Jul	14	2	396	51	1
39	14-Jul	14	2	393	58	1
40	13-Jul	14	2	415	57	1
41	10-Jul	14	3	451	54	2
42	9-Jul	14	2	526	51	1
43	8-Jul	14	2	407	54	1
44	7-Jul	14	2	408	44	1
45	6-Jul	14	2	386	59	1
46	3-Jul	14	2	433	52	1
47	2-Jul	14	3	560	50	2
48	1-Jul	14	2	461	50	1
49	30-Jun	14	4	684	45	2
50	29-Jun	14	5	641	31	2

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	1,908c	174c	8.35
03-Sep	2,082c	207c	11.03
01-Sep	1,875c	18c	0.96
31-Aug	1,857c	235c	14.48
26-Aug	1,622c	19c	1.17
25-Aug	1,604c	20c	1.22
24-Aug	1,623c	100c	6.54
21-Aug	1,524c	89c	6.23
19-Aug	1,434c	32c	2.18
18-Aug	1,466c	36c	2.50
17-Aug	1,431c	30c	2.15
14-Aug	1,401c	69c	4.67
13-Aug	1,469c	29c	1.94
12-Aug	1,498c	131c	9.55
11-Aug	1,368c	6c	0.41
10-Aug	1,362c	113c	9.03
06-Aug	1,249c	11c	0.91
04-Aug	1,238c	2c	0.15
31-Jul	1,236c	8c	0.61
30-Jul	1,229c	7c	0.53
29-Jul	1,235c	8c	0.61
28-Jul	1,228c	15c	1.21
27-Jul	1,243c	0	0

Stock Checklist

Price is above from 52 week high low average: 82%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Aug26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.05%	-0.01%	0

Syncom Formulations (India) Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements